ERBB2 and breast cancer: Because breast cancer is divided into distinct subtypes, we analyzed Dicer expression in different breast cancer subtypes and determined markedly lower Dicer expression in the luminal, human epidermal growth factor receptor 2-positive (HER+), and triple-negative breast cancer (TNBC) subtypes than in the normal breast tissue (Figure 2C).